LOCETAR 50 MG/ML MEDICINAL NAIL POLISH

2. What you need to know before using Locetar Medicinal Nail Varnish

A fungal infection is considered mild to moderate if it affects the nail plate (without involving the nail matrix) and is characterized by discoloration of the nail (white, yellow, or brown) and thickening, although the appearance may vary considerably.

If the infection is limited to the upper part of the nail, as shown in image 1 or 2, where there is no involvement of the nail matrix, only discoloration (white, yellow, or brown), consult your pharmacist.

If the infection appears as in photo 3 or 4, where involvement of the nail matrix and nail breakage can be seen, consult your doctor.

Do not use Locetar Medicinal Nail Varnish

• if you are allergic to amorolfine or any of the other components of this medicine (listed in section 6).

Children and Adolescents

This medicine is not recommended for use in children and adolescents (from 12 to 18 years) due to insufficient clinical experience in this age group.

Warnings and Precautions

Consult your doctor or pharmacist before starting to use this medicine.

• If you have a history of diabetes, immunological disorders (diseases that reduce the body's defenses), peripheral vascular disorders, wounds, pain in the nails, or severely damaged nails, skin conditions such as psoriasis, or any chronic skin condition, edema, or respiratory disorders (yellow nail syndrome).
• If you are diabetic, be careful when cutting your nails.
• If you develop sensitivity to the product, stop treatment and consult your doctor.
• During treatment, do not use artificial nails.
• After applying Locetar, wait at least 10 minutes before applying any cosmetic nail polish.
• Before reapplying Locetar, remove any cosmetic nail polish carefully.
• In patients undergoing treatment who regularly work with organic solvents, it is recommended to wear impermeable gloves to protect the hands.
• Avoid contact with eyes and mucous membranes. If accidental contact with the eyes occurs, rinse with plenty of water and consult an ophthalmologist if necessary.

This medicine may cause allergic reactions, some of which can be serious. If this occurs, discontinue treatment, remove the medicine immediately with a nail polish remover, and seek medical advice. The medicine should not be reapplied.

You should seek urgent medical attention if you experience any of the following symptoms:

• Difficulty breathing.
• Your face, lips, tongue, or throat are swollen.
• Your skin has developed a severe rash.

Using Locetar Medicinal Nail Varnish with other medicines

Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.

Pregnancy and Breastfeeding

Pregnancy

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. Treatment with Locetar will only be carried out if necessary, after the responsible doctor has carefully evaluated the benefits versus the possible risks.

Breastfeeding

It is not known whether it is safe to apply this medicine to breastfeeding women. Treatment with Locetar will only be carried out if necessary, after the responsible doctor has carefully evaluated the benefits versus the possible risks.

Driving and Using Machines

The influence of this medicine on the ability to drive or use machines is negligible or nonexistent.

Locetar contains alcohol (ethanol)

This medicine contains 481.3 mg of alcohol (ethanol) per milliliter of solution. It may cause a burning sensation on damaged skin.

Locetar contains ethanol, which is flammable and should not be used near an open flame, lit cigarettes, or certain devices (e.g., hair dryers).

3. How to use Locetar Medicinal Nail Varnish

Follow the instructions for administration of this medicine contained in this package leaflet or as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Method of administration: cutaneous use (only for use on the nails, not to be applied to the surrounding skin).

Locetar should only be used by adults.

Apply the solution 1 or 2 times a week, only to the affected nails of the hands or feet. Try to associate the use of the medicinal nail varnish with a hygiene habit, on 1 day of the week that you choose, and maintain this routine while the treatment lasts.

The required duration of treatment will depend mainly on the severity and location of the infection. It is usually 6 months for fingernails and 9 to 12 months for toenails.

If symptoms worsen or new symptoms appear, the clinical situation should be reevaluated. If no improvement is observed after 3 months of treatment, consult a doctor.

Method of application:

Attention:

Healthy nails should never be filed with the same file used for infected nails. Fungal infections are contagious. To prevent infection, avoid letting another person use the same file.

General hygiene measures should be applied to avoid the appearance of other infections or relapses.

Regular trimming of the nails is recommended to eliminate the infected parts of the nail.

In the case of coexistence of tinea pedis, it should be treated with an appropriate antifungal cream.

In case of doubt, consult a doctor or pharmacist.

If you use more Locetar Medicinal Nail Varnish than you should

This medicine is not to be ingested. IT IS FOR EXTERNAL USE ONLY.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or go to a medical center, or call the Toxicology Information Service, phone: 91 5620420, indicating the medicine and the amount ingested.

If you forget to use Locetar Medicinal Nail Varnish

Do not apply a double dose to make up for forgotten doses.

If you interrupt treatment with Locetar Medicinal Nail Varnish

If you interrupt treatment with Locetar before your nail(s) are clean or almost clean, the fungi may not have disappeared. In this case, the condition of your nails may worsen again.

If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.

4. Possible Side Effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Adverse reactions are rare. They may include nail changes (e.g., nail discoloration, nail breakage, and brittle nails). These reactions may also be related to the onychomycosis itself.

Rare (may affect up to 1 in 1,000 people)

• Nail change,
• Nail discoloration,
• Onychoclasis (nail breakage),
• Onychorexis (brittle nails).

Very rare (may affect up to 1 in 10,000 people)

• Burning sensation on the skin.

Frequency not known (cannot be estimated from the available data):

• Systemic allergic reaction (a serious allergic reaction that may be associated with swelling of the face, lips, tongue, or throat, difficulty breathing, and/or severe skin rash).
• Erythema, itching, contact dermatitis, urticaria, and blisters.

Reporting of Side Effects

If you experience any side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Locetar Medicinal Nail Varnish

Keep this medicine out of the sight and reach of children.

No special storage conditions are required.

Store in the original packaging.

Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date is the last day of the month indicated.

No special storage conditions are required.

Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Contents of the Pack and Further Information

Locetar Medicinal Nail Varnish Composition

• The active ingredient is amorolfine. Each milliliter of solution contains 50 milligrams of amorolfine.

• The other excipients are methacrylic acid copolymer, triacetin, butyl acetate, ethyl acetate, and 96% ethanol.

Appearance of the Product and Contents of the Pack

Ambber glass bottle with a polypropylene (HDPE) cap, containing 5 ml of solution.

The packaging includes: 30 cleaning wipes, in individual sachets, as well as 10 disposable spatulas and 30 nail files.

Ambber glass bottle with a polypropylene (HDPE) cap, containing 5 ml of solution, and a spatula integrated into the cap (LDPE).

The packaging includes 30 cleaning wipes, in individual sachets, and 30 nail files.

Only one of the packaging options may be marketed.

Marketing Authorization Holder

Laboratorios Galderma, S.A.

Serrano Galvache, 56

28033 Madrid

Spain

Manufacturer

Laboratoires Galderma

Alby sur Chéran (France)

Date of Last Revision of this Package Leaflet:October 2017

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.es/

.